JARID1B expression in human melanoma and benign melanocytic skin lesions

Melanoma Research

Volumn 23, Issue 1, 2013, Pages 8-12

  Kuaźbicki, Łukasz ^a   Lange, Dariusz ^b   Stra̧czyńska Niemiec, Anita ^b   Chwirot, Barbara W ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Benign nevus; Immunohistochemistry; JARID1B protein; Melanoma; Spatial expression pattern

Indexed keywords

JARID1B PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SKIN DEFECT;

HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEVUS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; SKIN NEOPLASMS; SPATIAL ANALYSIS;

EID: 84872062248     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32835d5d6f     Document Type: Article

References (8)

1. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010; 18:510-523
2. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141:583-594
3. Roesch A, Becker B, Meyer S, Wild P, Hafner C, Landthaler M, et al. Retinoblastoma-binding protein 2-homolog 1: A retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol 2005; 18: 1249-1257 (Pubitemid 43079925)
4. Fukunaga-Kalabis M, Roesch A, Herlyn M. From cancer stem cells to tumor maintenance in melanoma. J Invest Dermatol 2011; 131: 1600-1604
5. Radberger P, Radberger A, Bykov VJ, Seregard S, Economou MA. JARID1B protein expression and prognostic implications in uveal melanoma. Invest Ophthalmol Vis Sci 2012; 53:4442-4449
6. Xia X, Lemieux ME, Li W, Carroll JS, Brown M, Liu XS, et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 2009; 106: 4260-4265
7. Roesch A, Mueller AM, Stempfl T, Moehle C, Landthaler M, Vogt T. RBP2-H1/ JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer 2008; 122:1047-1057 (Pubitemid 351214002)
8. Sztramska A, Dymerska D, Chwirot BW. Skin layer-specific melan-A expression during progression of human cutaneous melanoma: Implications for diagnostic applications of the marker. Melanoma Res 2008; 18: 259-267